SciELO - Scientific Electronic Library Online

 
vol.12 issue2Programa de prevención de anemia falciforme (I): Evaluación de la indicación de electroforesis de hemoglobinaPrograma de prevención de anemia falciforme (III): La electroforesis de hemoglobina: indicación e interpretación author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Medicina General Integral

On-line version ISSN 1561-3038

Abstract

MARTIN RUIZ, MarcosRaúl. Programa de prevención de anemia falciforme (II): Evaluación del seguimiento de gestantes con hemoglobinas anormales. Rev Cubana Med Gen Integr [online]. 1996, vol.12, n.2, pp. 136-140. ISSN 1561-3038.

Some aspects of the Cuban Programme for Prevention of Sickle Cell Anemia were analyze in Havana City during 1992. All pregnants detected with abnormal hemoglobins received an appointment by telegram to get an explanation about the significance of findings; 62,2 % attended promptly to the appointment; 21,6 % came later, making necessary the use of other mechanisms of communication with pregnants; and 16,2 % never attended. All pregnants who went to the appointment accepted genetic counseling and were followed up. Only 47,6 % concluded testing of partner early enough for consideration of prenatal diagnosis. The results showed the need to reduce gestational age in order to determine the risk of the couple. This is possible by screaning pregnants at the first prenatal visit, by using more efficient methods for contacting with positive women, and by doing the test and informing the results faster.

Keywords : ANEMIA, SICKLE CELL [prevention and control]; NATIONAL HEALTH PROGRAMS; PRIMARY PREVENTION; FOLLOW-UP STUDIES; HEMOGLOBINS, ABNORMAL [analysis]; GENETIC COUNSELING; PRENATAL DIAGNOSIS.

        · abstract in Spanish     · text in Spanish

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License